1,213
Views
214
CrossRef citations to date
0
Altmetric
Review

Epidemiology and clinical impact of major comorbidities in patients with COPD

&
Pages 871-888 | Published online: 27 Aug 2014

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for diagnosis, management, and prevention of COPD2014 Available from: http://www.goldcopd.org/Accessed June 5, 2014
  • PutchaNPuhanMAHanselNNDrummondMBBoydCMImpact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001–2008COPD201310332433223713595
  • DivoMCoteCde TorresJComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
  • MillerJEdwardsLDAgustiAComorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespir Med201310791376138423791463
  • SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J20062861245125717138679
  • AlmagroPCalboEOchoa de EchaguenAMortality after hospitalization for COPDChest200212151441144812006426
  • ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
  • VanfleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
  • VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • ManninoDMAguayoSMPettyTLReddSCLow lung function and incident lung cancer in the United States: data from the first National Health and Nutrition Examination Survey follow-upArch Intern Med2003163121475148012824098
  • BalcellsEAntoJMGeaJCharacteristics of patients admitted for the first time for COPD exacerbationRespir Med200910391293130219427776
  • BegheBVerduriARocaMFabbriLMExacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPDEur Respir J201341499399523543648
  • FabbriLMBegheBAgustiACardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelinesThorax201166974574721653929
  • van ManenJGBindelsPJDekkerEWAdded value of co-morbidity in predicting health-related quality of life in COPD patientsRespir Med200195649650411421508
  • YeoJKarimovaGBansalSCo-morbidity in older patients with COPD: its impact on health service utilisation and quality of life, a community studyAge Ageing2006351333716364931
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • LaurinCMoullecGBaconSLLavoieKLImpact of anxiety and depression on chronic obstructive pulmonary disease exacerbation riskAm J Respir Crit Care Med2012185991892322246177
  • RizkallahJManSFSinDDPrevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysisChest2009135378679318812453
  • WellsJMDransfieldMTPathophysiology and clinical implications of pulmonary arterial enlargement in COPDInt J Chron Obstruct Pulmon Dis2013850952124235822
  • Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
  • RobertsCMStoneRALoweDPurseyNABuckinghamRJCo-morbidities and 90-day outcomes in hospitalized COPD exacerbationsCOPD20118535436121864116
  • McGarveyLPMagderSBurkhartDCause-specific mortality adjudication in the UPLIFT(R) COPD trial: findings and recommendationsRespir Med2012106451552122100536
  • AnthonisenNRSkeansMAWiseRAThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med2005142423323915710956
  • BerryCEWiseRAMortality in COPD: causes, risk factors, and preventionCOPD20107537538220854053
  • McGarveyLPJohnMAndersonJAZvarichMWiseRATORCH Clinical Endpoint CommitteeAscertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax200762541141517311843
  • YohannesAMWillgossTGBaldwinRCConnollyMJDepression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principlesInt J Geriatr Psychiatry201025121209122120033905
  • VogeleCvon LeupoldtAMental disorders in chronic obstructive pulmonary disease (COPD)Respir Med2008102576477318222685
  • KunikMERoundyKVeazeyCSurprisingly high prevalence of anxiety and depression in chronic breathing disordersChest200512741205121115821196
  • KunikMEVeazeyCCullyJACOPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trialPsychol Med200838338539617922939
  • KuhlKSchurmannWRiefWMental disorders and quality of life in COPD patients and their spousesInt J Chron Obstruct Pulmon Dis20083472773619281087
  • GudmundssonGGislasonTJansonCRisk factors for rehospitalisation in COPD: role of health status, anxiety and depressionEur Respir J200526341441916135721
  • GudmundssonGGislasonTJansonCDepression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countriesRespir Med20061001879315893921
  • WillgossTGYohannesAMAnxiety disorders in patients with COPD: a systematic reviewRespir Care201358585886622906542
  • AnecchinoCRossiEFanizzaCPrevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general populationInt J Chron Obstruct Pulmon Dis20072456757418268930
  • MapelDWPicchiMAHurleyJSUtilization in COPD: patient characteristics and diagnostic evaluationChest20001175 Suppl 2346S353S10843975
  • AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
  • BarrRGCelliBRManninoDMComorbidities, patient knowledge, and disease management in a national sample of patients with COPDAm J Med2009122434835519332230
  • KimJLeeJHKimYAssociation between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort studyBMC Pulm Med20131315123927016
  • HananiaNAMullerovaHLocantoreNWDeterminants of depression in the ECLIPSE chronic obstructive pulmonary disease cohortAm J Respir Crit Care Med2011183560461120889909
  • SchaneREWalterLCDinnoACovinskyKEWoodruffPGPrevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary diseaseJ Gen Intern Med200823111757176218690488
  • CafarellaPAEffingTWUsmaniZAFrithPATreatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature reviewRespirology201217462763822309179
  • van den BemtLSchermerTBorHThe risk for depression comorbidity in patients with COPDChest2009135110811418689578
  • AtlantisEFaheyPCochraneBSmithSBidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysisChest2013144376677723429910
  • MaurerJRebbapragadaVBorsonSAnxiety and depression in COPD: current understanding, unanswered questions, and research needsChest2008134Suppl 443S56S18842932
  • BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
  • BurgelPREscamillaRPerezTImpact of comorbidities on COPD-specific health-related quality of lifeRespir Med2013107223324123098687
  • WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
  • CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol2006161637016039877
  • de Lucas-RamosPIzquierdo-AlonsoJLRodriguez-Gonzalez MoroJMChronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study)Int J Chron Obstruct Pulmon Dis2012767968623055717
  • FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
  • MapelDWDedrickDDavisKTrends and cardiovascular comorbidities of COPD patients in the Veterans Administration medical system,1991–1999COPD200521354117136959
  • MascarenhasJAzevedoABettencourtPCoexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortalityCurr Opin Pulm Med201016210611120042977
  • de Miguel DiezJChancafe MorganJJimenez GarciaRThe association between COPD and heart failure risk: a reviewInt J Chron Obstruct Pulmon Dis2013830531223847414
  • HalpinDMDecramerMCelliBKestenSLeimerITashkinDPRisk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT(R) trialLung2011189426126821678045
  • BarrRGBluemkeDAAhmedFSPercent emphysema, airflow obstruction, and impaired left ventricular fillingN Engl J Med2010362321722720089972
  • GrauMBarrRGLimaJAPercent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle StudiesChest2013144113614423450302
  • WatzHWaschkiBMagnussenHEmphysema, airflow obstruction, and left ventricular fillingN Engl J Med20103621716381639 author reply 1640–163120427814
  • StavemKAaserESandvikLLung function, smoking and mortality in a 26-year follow-up of healthy middle-aged malesEur Respir J200525461862515802334
  • SinDDManSFChronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortalityProc Am Thorac Soc20052181116113462
  • IversenKKKjaergaardJAkkanDThe prognostic importance of lung function in patients admitted with heart failureEur J Heart Fail201012768569120395261
  • KeeKNaughtonMTHeart failure and the lungCirc J201074122507251621041971
  • GuderGRuttenFHBrennerSThe impact of heart failure on the classification of COPD severityJ Card Fail201218863764422858080
  • McAllisterDAMaclayJDMillsNLDiagnosis of myocardial infarction following hospitalisation for exacerbation of COPDEur Respir J20123951097110322323574
  • BrekkePHOmlandTSmithPSoysethVUnderdiagnosis of myocardial infarction in COPD: Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbationRespir Med200810291243124718595681
  • DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
  • McAllisterDAMaclayJDMillsNLArterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007176121208121417885263
  • EickhoffPValipourAKissDDeterminants of systemic vascular function in patients with stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008178121211121818836149
  • VanfleterenLESpruitMAGroenenMTArterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitationEur Respir J20144351306131524311762
  • LahousseLvan den BouwhuijsenQJLothDWChronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam StudyAm J Respir Crit Care Med20131871586423144329
  • ThomsenMDahlMLangePVestboJNordestgaardBGInflammatory biomarkers and comorbidities in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121861098298822983959
  • PatelARDonaldsonGCMackayAJWedzichaJAHurstJRThe impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPDChest2012141485185721940771
  • CoteCGCasanovaCMarinJMValidation and comparison of reference equations for the 6-min walk distance testEur Respir J200831357157817989117
  • ChangCLRobinsonSCMillsGDBiochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPDThorax201166976476821474497
  • StefanMSRothbergMBPriyaAPekowPSAuDHLindenauerPKAssociation between beta-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertensionThorax2012671197798422941975
  • TsiligianniIGKosmasEVan der MolenTTzanakisNManaging comorbidity in COPD: a difficult taskCurr Drug Targets201314215817623256716
  • GottliebSSMcCarterRJVogelRAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med199833984894979709041
  • SalpeterSOrmistonTSalpeterECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD00356616235327
  • EkstromMPHermanssonABStromKEEffects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187771572023328521
  • MateraMGCalzettaLRinaldiBCazzolaMTreatment of COPD: moving beyond the lungsCurr Opin Pharmacol201212331532222552103
  • WangMTLoYWTsaiCLStatin use and risk of COPD exacerbation requiring hospitalizationAm J Med2013126759860623684060
  • JandaSParkKFitzGeraldJMEtminanMSwistonJStatins in COPD: a systematic reviewChest2009136373474319376844
  • VestboJAndersonJBrookRDThe Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocolEur Respir J20134151017102223018908
  • CelliBDecramerMKestenSMortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20091801094895519729663
  • WrobelJPThompsonBRWilliamsTJMechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic reviewJ Heart Lung Transplant201231655756422502811
  • SeegerWAdirYBarberaJAPulmonary hypertension in chronic lung diseasesJ Am Coll Cardiol201362Suppl 25D109D11624355635
  • ScharfSMIqbalMKellerCHemodynamic characterization of patients with severe emphysemaAm J Respir Crit Care Med2002166331432212153963
  • ThabutGDauriatGSternJBPulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantationChest200512751531153615888824
  • MatthayRASchwarzMIEllisJHJrPulmonary artery hypertension in chronic obstructive pulmonary disease: determination by chest radiographyInvest Radiol1981162951007216709
  • KesslerRFallerMFourgautGMennecierBWeitzenblumEPredictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199915911581649872834
  • KellerCAShepardJWJrChunDSVasquezPDolanGFPulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysisChest19869021851923731890
  • SimsMWMargolisDJLocalioARPanettieriRAKawutSMChristieJDImpact of pulmonary artery pressure on exercise function in severe COPDChest2009136241241919318664
  • ChaouatABugnetASKadaouiNSevere pulmonary hypertension and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172218919415831842
  • Oswald-MammosserMWeitzenblumEQuoixEPrognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressureChest19951075119311987750305
  • DoiMNakanoKHiramotoTKohnoNSignificance of pulmonary artery pressure in emphysema patients with mild-to-moderate hypoxemiaRespir Med200397891592012924518
  • CutticaMJKalhanRShlobinOACategorization and impact of pulmonary hypertension in patients with advanced COPDRespir Med2010104121877188220547449
  • AndersenCUMellemkjaerSNielsen-KudskJEBendstrupEHilbergOSimonsenUPulmonary hypertension in chronic obstructive and interstitial lung diseasesInt J Cardiol201316831795180423849967
  • AndersenKHIversenMKjaergaardJPrevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary diseaseJ Heart Lung Transplant201231437338022226804
  • ArcasoySMChristieJDFerrariVAEchocardiographic assessment of pulmonary hypertension in patients with advanced lung diseaseAm J Respir Crit Care Med2003167573574012480614
  • FisherMRCrinerGJFishmanAPEstimating pulmonary artery pressures by echocardiography in patients with emphysemaEur Respir J200730591492117652313
  • FisherMRForfiaPRChameraEAccuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertensionAm J Respir Crit Care Med2009179761562119164700
  • HoeperMMBogaardHJCondliffeRDefinitions and diagnosis of pulmonary hypertensionJ Am Coll Cardiol201362Suppl 25D42D5024355641
  • FishmanAMartinezFNaunheimKA randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysemaN Engl J Med2003348212059207312759479
  • SciurbaFCErnstAHerthFJA randomized study of endobronchial valves for advanced emphysemaN Engl J Med2010363131233124420860505
  • WrobelJPThompsonBRSnellGIWilliamsTJPreoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPDLung2012190663564323064489
  • PomsADTurnerMFarberHWMeltzerLAMcGoonMDComorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysisChest2013144116917623348820
  • BoerrigterBGBogaardHJTripPVentilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertensionChest201214251166117422556320
  • GalieNCorrisPAFrostAUpdated treatment algorithm of pulmonary arterial hypertensionJ Am Coll Cardiol201362Suppl 25D60D7224355643
  • de TorresJPMarinJMCasanovaCLung cancer in patients with chronic obstructive pulmonary disease – incidence and predicting factorsAm J Respir Crit Care Med2011184891391921799072
  • YoungRPHopkinsRJChristmasTBlackPNMetcalfPGambleGDCOPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEur Respir J200934238038619196816
  • KiriVASorianoJVisickGFabbriLRecent trends in lung cancer and its association with COPD: an analysis using the UK GP Research DatabasePrim Care Respir J2010191576119756330
  • RodriguezLAWallanderMAMartin-MerinoEJohanssonSHeart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care studyRespir Med2010104111691169920483577
  • HoughtonAMMechanistic links between COPD and lung cancerNat Rev Cancer201313423324523467302
  • YangIAHollowayJWFongKMGenetic susceptibility to lung cancer and co-morbiditiesJ Thorac Dis20135Suppl 5S454S46224163739
  • LimEBaldwinDBecklesMGuidelines on the radical management of patients with lung cancerThorax201065Suppl 3iii1iii2720940263
  • SekineYIwataTChiyoMMinimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary diseaseAnn Thorac Surg2003762356361 discussion 36212902063
  • WigginsJStricklandBTurner-WarwickMCombined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessmentRespir Med19908453653692247666
  • UsuiKTanaiCTanakaYNodaHIshiharaTThe prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancerRespirology201116232633121114711
  • KitaguchiYFujimotoKHanaokaMKawakamiSHondaTKuboKClinical characteristics of combined pulmonary fibrosis and emphysemaRespirology201015226527120051048
  • PapirisSATriantafillidouCManaliEDCombined pulmonary fibrosis and emphysemaExpert Rev Respir Med2013711931 quiz 3223362797
  • CottinVNunesHBrilletPYCombined pulmonary fibrosis and emphysema: a distinct underrecognised entityEur Respir J200526458659316204587
  • CottinVThe impact of emphysema in pulmonary fibrosisEur Respir J201322128153157
  • FearyJRRodriguesLCSmithCJHubbardRBGibsonJEPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax2010651195696220871122
  • CaugheyGEPreissAKVitryAIGilbertALRougheadEEComorbid diabetes and COPD: impact of corticosteroid use on diabetes complicationsDiabetes Care201336103009301423735725
  • Graat-VerboomLWoutersEFSmeenkFWvan den BorneBELundeRSpruitMACurrent status of research on osteoporosis in COPD: a systematic reviewEur Respir J200934120921819567604
  • JorgensenNRSchwarzPHolmeIHenriksenBMPetersenLJBackerVThe prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional studyRespir Med2007101117718516677808
  • FergusonGTCalverleyPMAndersonJAPrevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health studyChest200913661456146519581353
  • RommeEARuttenEPSmeenkFWSpruitMAMenheerePPWoutersEFVitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary diseaseAnn Med2013451919622462562
  • Graat-VerboomLSpruitMAvan den BorneBECorrelates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic componentRespir Med200910381143115119304474
  • OharaTHiraiTMuroSRelationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPDChest200813461244124918641115
  • ZhangPFPanLLuoZYZhaoHJCaiSXInterrelationship of circulating matrix metalloproteinase–9, TNF-alpha, and OPG/RANK/RANKL systems in COPD patients with osteoporosisCOPD201310665065623845033
  • BaiPSunYJinJDisturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosisRespir Res20111215722176920
  • HardyRCooperMSBone loss in inflammatory disordersJ Endocrinol2009201330932019443863
  • KiyokawaHMuroSOgumaTImpact of COPD exacerbations on osteoporosis assessed by chest CT scanCOPD20129323524222360380
  • HarrisonRASiminoskiKVethanayagamDMajumdarSROsteoporosis-related kyphosis and impairments in pulmonary function: a systematic reviewJ Bone Miner Res200722344745717181402
  • LokeYKCavallazziRSinghSRisk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studiesThorax201166869970821602540
  • MathioudakisAGAmanetopoulouSGGialmanidisIPImpact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?Respirology201318114715322985270
  • MokhlesiBMorrisALHuangCFCurcioAJBarrettTAKampDWIncreased prevalence of gastroesophageal reflux symptoms in patients with COPDChest200111941043104811296167
  • CasanovaCBaudetJSdel Valle VelascoMIncreased gastro-oesophageal reflux disease in patients with severe COPDEur Respir J200423684184515218995
  • SakaeTMPizzichiniMMTeixeiraPJda SilvaRMTrevisolDJPizzichiniEExacerbations of COPD and symptoms of gastro-esophageal reflux: a systematic review and meta-analysisJ Bras Pneumol201339325927123857694
  • Rascon-AguilarIEPamerMWludykaPCuryJVegaKJPoorly treated or unrecognized GERD reduces quality of life in patients with COPDDig Dis Sci20115671976198021221789
  • HuangKWLuoJCLeuHBChronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based studyAliment Pharmacol Ther201235779680222348540
  • SivaRBirringSSBerryMRowbottomAPavordIDPeptic ulceration, Helicobacter pylori seropositivity and chronic obstructive pulmonary diseaseRespirology201318472873123438259
  • SasakiTNakayamaKYasudaHA randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patientsJ Am Geriatr Soc20095781453145719515110
  • IncalziRACorsonelloAPedoneCChronic renal failure: a neglected comorbidity of COPDChest2010137483183719903974
  • van DeursenVMUrsoRLarocheCCo-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot SurveyEur J Heart Fail201416110311124453099
  • WuCCamachoFTKingSB3rdRisk stratification for long-term mortality after percutaneous coronary interventionCirc Cardiovasc Interv201471808724425588
  • CampoGGuastarobaPMarzocchiAImpact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary interventionChest2013144375075723392738